Lifeboat Foundation

The research, which appears this week in Science, examined the electronic and magnetic behavior of a “strange metal” compound of ytterbium, rhodium and silicon as it both neared and passed through a critical transition at the boundary between two well-studied quantum phases.

The study at Rice University and Vienna University of Technology (TU Wien) provides the strongest direct evidence to date of entanglement’s role in bringing about quantum criticality, said study co-author Qimiao Si of Rice.

“When we think about quantum entanglement, we think about small things,” Si said. “We don’t associate it with macroscopic objects. But at a quantum critical point, things are so collective that we have this chance to see the effects of entanglement, even in a metallic film that contains billions of billions of quantum mechanical objects.”

Bringing together artificial intelligence and neuroscience promises to yield benefits for both fields.

SAN FRANCISCO – Startup Skylo emerged from stealth mode Jan. 21 with $116 million in the bank and plans to connect devices by transferring data over existing geostationary communications satellites.

“The key challenge we wanted to address was how data was going to be moved from machines and sensors outside of the areas where traditionally connectivity has existed,” Parthsarathi “Parth” Trivedi, Skylo co-founder and CEO, told SpaceNews. “If we could lower the cost of providing ubiquitous, affordable and reliable connectivity, there would be a phenomenal number of applications.”

Skylo raised $13 million in a Series A investment round led by DCM Ventures and Innovation Endeavors with participation by Boeing HorizonX and Moore Strategic Ventures. In its latest Series B round led by SoftBank with participation by all the firm’s previous investors, Skylo raised $103 million, according to the firm’s Jan. 21 news release.

Updated at 9:50 p.m. Eastern.

WASHINGTON — A green propulsion startup with more than $1 million in sales says it is gaining traction in the smallsat market while funding its own small launch vehicle.

Dawn Aerospace, based in New Zealand and the Netherlands, has its first propulsion system launching in March on a D-Orbit cubesat aboard a Vega rocket. A second is scheduled to launch on an Indian PSLV in the second quarter of 2020 on a cubesat for Hiber, a Dutch Internet of Things startup. Dawn Aerospace also has contracts from the New Zealand Space Agency and the U.S. Air Force, Dawn Aerospace CEO Jeroen Wink said in an interview.

Scientists have discovered a form of natural selection that doesn’t rely on DNA.

Circa 2016

A team from the University of Leicester have examined the likely materials that would go into building Star Trek’s photon torpedoes, and they find that it might just be possible to create the tech.

Public health officials have confirmed the first U.S. case of a mysterious coronavirus that has sickened hundreds of people in China, the Centers for Disease Control and Prevention said Tuesday.

A Snohomish County, Washington State resident who was returning from China on Jan. 15 was diagnosed with the Wuhan coronavirus, according to the CDC.

Officials said the patient, a male in his 30s, is “very healthy.” He is currently being isolated at a medical center in the state “out of caution” and “poses little risk” to the public, they said. The CDC said the man reached out to local health authorities last week once he started experiencing pneumonia-like symptoms.

SAN FRANCISCO, Jan. 21, 2020 /PRNewswire/ — Capella Space, an information services company providing Earth observation data on demand, today unveiled its evolved satellite design to enable on-demand observations of anywhere on Earth. Informed by extensive customer feedback and findings from the launch of Denali, Capella’s testbed satellite, the re-engineered design features a suite of technological innovations to deliver timely, flexible and frequent sub-0.5 meter very high quality images to the market. The enhanced technology package will deliver the most advanced offering for small satellite SAR imagery on the market.

This year marks the Eighth Review Conference (RevCon) of the Biological Toxins and Weapons Convention (BWC). At the same time, ongoing international efforts to further and more deeply investigate the brain’s complex neuronal circuitry are creating unprecedented capabilities to both understand and control neurological processes of thought, emotion, and behavior. These advances have tremendous promise for human health, but the potential for their misuse has also been noted, with most discussions centering on research and development of agents that are addressed by existing BWC and Chemical Weapons Convention (CWC) proscriptions. In this article, we discuss the dual-use possibilities fostered by employing emergent biotechnologic techniques and tools—specifically, novel gene editors like clustered regular interspaced short palindromic repeats (CRISPR)—to produce neuroweapons. Based on our analyses, we posit the strong likelihood that development of genetically modified or created neurotropic substances will advance apace with other gene-based therapeutics, and we assert that this represents a novel—and realizable—path to creating potential neuroweapons. In light of this, we propose that it will be important to re-address current categorizations of weaponizable tools and substances, so as to better inform and generate tractable policy to enable improved surveillance and governance of novel neuroweapons.

Keywords: : CRISPR, Gene editing, Neuroweapon, Neurotherapeutic pathways, Dual-use neuroscience, Biosecurity policy.

T his year marks the Eighth Review Conference (RevCon) of the Biological Toxins and Weapons Convention (BWC), the purpose of which is to ensure that the convened parties’ directives continue to be relevant to and viable for prohibiting the development, production, and stockpiling of biological weapons in the face of newly emerging scientific advancements and biotechnologies. Apropos of issues raised at previous RevCons and elsewhere, there are growing concerns about current and future weaponization of neurobiological agents and tools (ie, “neuroweapons”^1–6).